Paediatric Endocrinology

30 November 2017
medwireNews: Findings from a database analysis suggest that salt supplementation may not influence medication doses or height and weight in infants with congenital adrenal hyperplasia (CAH). The study, which is published in Hormone Research in Paediatrics, included data from 311 patients (153 female, 205 male) with salt-wasting CAH,... Read More
30 October 2017
medwireNews: Higher doses of vitamin D3 than currently recommended may be needed to achieve vitamin D sufficiency in schoolchildren living at northern latitudes, show the results of a randomised trial. However, the researchers stress that all three supplemental doses used – 600, 1000 or 2000 IU/day for 6 months – prevented severe vitamin D... Read More
30 October 2017
medwireNews: Factors including age, thyroid hormone levels and weight loss prior to diagnosis influence whether children gain weight after being treated for Graves’ disease, study results show. Perrin White (University of Texas Southwestern Medical Center, Dallas, USA) and co-researchers found that 222 paediatric patients with Graves’ disease... Read More
29 September 2017
medwireNews: Growth hormone (GH) treatment of children with Silver-Russell Syndrome (SRS)) is associated with early adrenarche, but this does not compromise their growth response, report researchers. The 34 boys and 28 girls in the study reached adrenarche (dehydroepiandrosterone sulphate [DHEAS] level >500 ng/mL) at a median age of 9.2 and... Read More
31 August 2017
medwireNews: Neonatal diabetes could be detected as early as day 5 of life using glucose measurements from dried blood spots, researchers report. “Earlier diagnosis by systematic screening could lead to prompt genetic diagnosis and targeted treatment, thereby avoiding the most severe sequelae of hyperglycaemia in neonates”, say Timothy... Read More
31 August 2017
medwireNews: The Infacort® hydrocortisone preparation of taste-masked granules can be used in children of all ages, including neonates, report researchers. Infacort® (Diurnal Limited, Cardiff, UK) has undergone an as yet unpublished phase III trial in Europe, and the manufacturer submitted it for European marketing authorisation at the end of... Read More